Dana-Farber Cancer Institute/Brigham and Women's Cancer Center.
J Natl Compr Canc Netw. 2013 Jan 1;11(1):11-7. doi: 10.6004/jnccn.2013.0004.
These NCCN Guidelines Insights highlight the important updates/changes specific to the management of relapsed or progressive disease in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma. These changes include the addition of new regimens as options for salvage therapy and strategies to mitigate the adverse effects and risks associated with newer regimens for the treatment of multiple myeloma.
这些 NCCN 指南解读突出了 2013 版 NCCN 肿瘤学多发性骨髓瘤临床实践指南中针对复发性或进行性疾病管理的重要更新/变化。这些变化包括增加新方案作为挽救治疗的选择，以及减轻与治疗多发性骨髓瘤的新方案相关的不良反应和风险的策略。
